Hospital Universitario de Cruces-ko ikertzaileekin lankidetzan egindako argitalpenak (22)

2024

  1. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study

    Neurology Perspectives, Vol. 4, Núm. 1

2022

  1. The real-world effectiveness and safety of perampanel in Europe: A scoping review

    Epilepsy and Behavior, Vol. 134

2021

  1. Relationship between sleep quality and cognitive performance in patients with epilepsy

    Epilepsy and Behavior, Vol. 122

2020

  1. Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs

    Seizure, Vol. 83, pp. 48-56

2019

  1. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

  2. Reactive Disruption of the Hippocampal Neurogenic Niche After Induction of Seizures by Injection of Kainic Acid in the Amygdala

    Frontiers in Cell and Developmental Biology, Vol. 7

2018

  1. Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy

    Epilepsy and Behavior, Vol. 84, pp. 93-98

  2. Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

    Epilepsia, Vol. 59, Núm. 9, pp. 1727-1739

  3. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

2017

  1. Cardiovascular autonomic and hemodynamic responses to vagus nerve stimulation in drug-resistant epilepsy

    Seizure, Vol. 45, pp. 56-60

  2. VNS and pregnancy: A multicentric experience of four cases

    Acta Neurologica Scandinavica

2016

  1. Neuronal Hyperactivity Disturbs ATP Microgradients, Impairs Microglial Motility, and Reduces Phagocytic Receptor Expression Triggering Apoptosis/Microglial Phagocytosis Uncoupling

    PLoS Biology, Vol. 14, Núm. 5

  2. One-year clinical experience of perampanel in Spain: A multicentre study of efficacy and tolerability

    Epileptic Disorders, Vol. 18, Núm. 2, pp. 173-180

2015

  1. Vagus nerve stimulation therapy for treatment-resistant epilepsy: A 15-year experience at a single institution

    Clinical Neurology and Neurosurgery, Vol. 137, pp. 89-93

2012

  1. Successful outcome of episodes of status epilepticus after vagus nerve stimulation: A multicenter study

    European Journal of Neurology, Vol. 19, Núm. 9, pp. 1219-1223

2011

  1. Predictive factors for a good prognosis following surgery for temporal lobe epilepsy: A cohort study in Spain

    Epileptic Disorders, Vol. 13, Núm. 1, pp. 36-46

  2. Relationship between sleep and dysautonomic symptoms assessed by self-report scales

    Movement Disorders

2009

  1. Application of depression criteria (DSM-IV) in patients with Parkinson's disease

    Clinical Neurology and Neurosurgery, Vol. 111, Núm. 8, pp. 665-669

2008

  1. Fluctuaciones motoras y discinesias en la enfermedad de Parkinson: Variables que discriminan ambas complicaciones en una muestra de 285 pacientes

    Neurologia, Vol. 23, Núm. 8, pp. 494-498

2007

  1. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease

    European Neurology, Vol. 57, Núm. 3, pp. 161-165